Global Cilostazol Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Cilostazol market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
United States market for Cilostazol is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Cilostazol is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Cilostazol is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Cilostazol players cover Pfizer, Teva, Otsuka Pharmaceutical, Novartis, Mylan, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Cilostazol Industry Forecast” looks at past sales and reviews total world Cilostazol sales in 2024, providing a comprehensive analysis by region and market sector of projected Cilostazol sales for 2025 through 2031. With Cilostazol sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cilostazol industry.
This Insight Report provides a comprehensive analysis of the global Cilostazol landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cilostazol portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cilostazol market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cilostazol and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cilostazol.
This report presents a comprehensive overview, market shares, and growth opportunities of Cilostazol market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Cilostazol market?
What factors are driving Cilostazol market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Cilostazol market opportunities vary by end market size?
How does Cilostazol break out by Type, by Application?
The global Cilostazol market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
United States market for Cilostazol is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Cilostazol is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Cilostazol is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Cilostazol players cover Pfizer, Teva, Otsuka Pharmaceutical, Novartis, Mylan, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Cilostazol Industry Forecast” looks at past sales and reviews total world Cilostazol sales in 2024, providing a comprehensive analysis by region and market sector of projected Cilostazol sales for 2025 through 2031. With Cilostazol sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cilostazol industry.
This Insight Report provides a comprehensive analysis of the global Cilostazol landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cilostazol portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cilostazol market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cilostazol and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cilostazol.
This report presents a comprehensive overview, market shares, and growth opportunities of Cilostazol market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Injection Cilostazol
- Freeze-dried Powder Cilostazol
- Oral Cilostazol
- Hospital
- Clinic
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer
- Teva
- Otsuka Pharmaceutical
- Novartis
- Mylan
- Squibb
- Sandoz
- Hikma Pharmaceuticals
- GSK
- Mayne Pharma
- Bedford Laboratories
- Abbott
- Takeda
- Zhejiang Weikang Pharmaceutical
- Chongqing Pharscin pharmaceutical
- Chengdu Leer Pharmaceutical
- Yantai Yisheng Pharmaceutical
- Cadila Pharmaceuticals
What is the 10-year outlook for the global Cilostazol market?
What factors are driving Cilostazol market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Cilostazol market opportunities vary by end market size?
How does Cilostazol break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cilostazol Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Cilostazol by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Cilostazol by Country/Region, 2020, 2024 & 2031
2.2 Cilostazol Segment by Type
2.2.1 Injection Cilostazol
2.2.2 Freeze-dried Powder Cilostazol
2.2.3 Oral Cilostazol
2.3 Cilostazol Sales by Type
2.3.1 Global Cilostazol Sales Market Share by Type (2020-2025)
2.3.2 Global Cilostazol Revenue and Market Share by Type (2020-2025)
2.3.3 Global Cilostazol Sale Price by Type (2020-2025)
2.4 Cilostazol Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Cilostazol Sales by Application
2.5.1 Global Cilostazol Sale Market Share by Application (2020-2025)
2.5.2 Global Cilostazol Revenue and Market Share by Application (2020-2025)
2.5.3 Global Cilostazol Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Cilostazol Breakdown Data by Company
3.1.1 Global Cilostazol Annual Sales by Company (2020-2025)
3.1.2 Global Cilostazol Sales Market Share by Company (2020-2025)
3.2 Global Cilostazol Annual Revenue by Company (2020-2025)
3.2.1 Global Cilostazol Revenue by Company (2020-2025)
3.2.2 Global Cilostazol Revenue Market Share by Company (2020-2025)
3.3 Global Cilostazol Sale Price by Company
3.4 Key Manufacturers Cilostazol Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Cilostazol Product Location Distribution
3.4.2 Players Cilostazol Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR CILOSTAZOL BY GEOGRAPHIC REGION
4.1 World Historic Cilostazol Market Size by Geographic Region (2020-2025)
4.1.1 Global Cilostazol Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Cilostazol Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Cilostazol Market Size by Country/Region (2020-2025)
4.2.1 Global Cilostazol Annual Sales by Country/Region (2020-2025)
4.2.2 Global Cilostazol Annual Revenue by Country/Region (2020-2025)
4.3 Americas Cilostazol Sales Growth
4.4 APAC Cilostazol Sales Growth
4.5 Europe Cilostazol Sales Growth
4.6 Middle East & Africa Cilostazol Sales Growth
5 AMERICAS
5.1 Americas Cilostazol Sales by Country
5.1.1 Americas Cilostazol Sales by Country (2020-2025)
5.1.2 Americas Cilostazol Revenue by Country (2020-2025)
5.2 Americas Cilostazol Sales by Type (2020-2025)
5.3 Americas Cilostazol Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cilostazol Sales by Region
6.1.1 APAC Cilostazol Sales by Region (2020-2025)
6.1.2 APAC Cilostazol Revenue by Region (2020-2025)
6.2 APAC Cilostazol Sales by Type (2020-2025)
6.3 APAC Cilostazol Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Cilostazol by Country
7.1.1 Europe Cilostazol Sales by Country (2020-2025)
7.1.2 Europe Cilostazol Revenue by Country (2020-2025)
7.2 Europe Cilostazol Sales by Type (2020-2025)
7.3 Europe Cilostazol Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cilostazol by Country
8.1.1 Middle East & Africa Cilostazol Sales by Country (2020-2025)
8.1.2 Middle East & Africa Cilostazol Revenue by Country (2020-2025)
8.2 Middle East & Africa Cilostazol Sales by Type (2020-2025)
8.3 Middle East & Africa Cilostazol Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Cilostazol
10.3 Manufacturing Process Analysis of Cilostazol
10.4 Industry Chain Structure of Cilostazol
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Cilostazol Distributors
11.3 Cilostazol Customer
12 WORLD FORECAST REVIEW FOR CILOSTAZOL BY GEOGRAPHIC REGION
12.1 Global Cilostazol Market Size Forecast by Region
12.1.1 Global Cilostazol Forecast by Region (2026-2031)
12.1.2 Global Cilostazol Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Cilostazol Forecast by Type (2026-2031)
12.7 Global Cilostazol Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Cilostazol Product Portfolios and Specifications
13.1.3 Pfizer Cilostazol Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Teva
13.2.1 Teva Company Information
13.2.2 Teva Cilostazol Product Portfolios and Specifications
13.2.3 Teva Cilostazol Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Teva Main Business Overview
13.2.5 Teva Latest Developments
13.3 Otsuka Pharmaceutical
13.3.1 Otsuka Pharmaceutical Company Information
13.3.2 Otsuka Pharmaceutical Cilostazol Product Portfolios and Specifications
13.3.3 Otsuka Pharmaceutical Cilostazol Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Otsuka Pharmaceutical Main Business Overview
13.3.5 Otsuka Pharmaceutical Latest Developments
13.4 Novartis
13.4.1 Novartis Company Information
13.4.2 Novartis Cilostazol Product Portfolios and Specifications
13.4.3 Novartis Cilostazol Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Novartis Main Business Overview
13.4.5 Novartis Latest Developments
13.5 Mylan
13.5.1 Mylan Company Information
13.5.2 Mylan Cilostazol Product Portfolios and Specifications
13.5.3 Mylan Cilostazol Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Mylan Main Business Overview
13.5.5 Mylan Latest Developments
13.6 Squibb
13.6.1 Squibb Company Information
13.6.2 Squibb Cilostazol Product Portfolios and Specifications
13.6.3 Squibb Cilostazol Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Squibb Main Business Overview
13.6.5 Squibb Latest Developments
13.7 Sandoz
13.7.1 Sandoz Company Information
13.7.2 Sandoz Cilostazol Product Portfolios and Specifications
13.7.3 Sandoz Cilostazol Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Sandoz Main Business Overview
13.7.5 Sandoz Latest Developments
13.8 Hikma Pharmaceuticals
13.8.1 Hikma Pharmaceuticals Company Information
13.8.2 Hikma Pharmaceuticals Cilostazol Product Portfolios and Specifications
13.8.3 Hikma Pharmaceuticals Cilostazol Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Hikma Pharmaceuticals Main Business Overview
13.8.5 Hikma Pharmaceuticals Latest Developments
13.9 GSK
13.9.1 GSK Company Information
13.9.2 GSK Cilostazol Product Portfolios and Specifications
13.9.3 GSK Cilostazol Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 GSK Main Business Overview
13.9.5 GSK Latest Developments
13.10 Mayne Pharma
13.10.1 Mayne Pharma Company Information
13.10.2 Mayne Pharma Cilostazol Product Portfolios and Specifications
13.10.3 Mayne Pharma Cilostazol Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Mayne Pharma Main Business Overview
13.10.5 Mayne Pharma Latest Developments
13.11 Bedford Laboratories
13.11.1 Bedford Laboratories Company Information
13.11.2 Bedford Laboratories Cilostazol Product Portfolios and Specifications
13.11.3 Bedford Laboratories Cilostazol Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Bedford Laboratories Main Business Overview
13.11.5 Bedford Laboratories Latest Developments
13.12 Abbott
13.12.1 Abbott Company Information
13.12.2 Abbott Cilostazol Product Portfolios and Specifications
13.12.3 Abbott Cilostazol Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Abbott Main Business Overview
13.12.5 Abbott Latest Developments
13.13 Takeda
13.13.1 Takeda Company Information
13.13.2 Takeda Cilostazol Product Portfolios and Specifications
13.13.3 Takeda Cilostazol Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Takeda Main Business Overview
13.13.5 Takeda Latest Developments
13.14 Zhejiang Weikang Pharmaceutical
13.14.1 Zhejiang Weikang Pharmaceutical Company Information
13.14.2 Zhejiang Weikang Pharmaceutical Cilostazol Product Portfolios and Specifications
13.14.3 Zhejiang Weikang Pharmaceutical Cilostazol Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Zhejiang Weikang Pharmaceutical Main Business Overview
13.14.5 Zhejiang Weikang Pharmaceutical Latest Developments
13.15 Chongqing Pharscin pharmaceutical
13.15.1 Chongqing Pharscin pharmaceutical Company Information
13.15.2 Chongqing Pharscin pharmaceutical Cilostazol Product Portfolios and Specifications
13.15.3 Chongqing Pharscin pharmaceutical Cilostazol Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Chongqing Pharscin pharmaceutical Main Business Overview
13.15.5 Chongqing Pharscin pharmaceutical Latest Developments
13.16 Chengdu Leer Pharmaceutical
13.16.1 Chengdu Leer Pharmaceutical Company Information
13.16.2 Chengdu Leer Pharmaceutical Cilostazol Product Portfolios and Specifications
13.16.3 Chengdu Leer Pharmaceutical Cilostazol Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Chengdu Leer Pharmaceutical Main Business Overview
13.16.5 Chengdu Leer Pharmaceutical Latest Developments
13.17 Yantai Yisheng Pharmaceutical
13.17.1 Yantai Yisheng Pharmaceutical Company Information
13.17.2 Yantai Yisheng Pharmaceutical Cilostazol Product Portfolios and Specifications
13.17.3 Yantai Yisheng Pharmaceutical Cilostazol Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Yantai Yisheng Pharmaceutical Main Business Overview
13.17.5 Yantai Yisheng Pharmaceutical Latest Developments
13.18 Cadila Pharmaceuticals
13.18.1 Cadila Pharmaceuticals Company Information
13.18.2 Cadila Pharmaceuticals Cilostazol Product Portfolios and Specifications
13.18.3 Cadila Pharmaceuticals Cilostazol Sales, Revenue, Price and Gross Margin (2020-2025)
13.18.4 Cadila Pharmaceuticals Main Business Overview
13.18.5 Cadila Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Cilostazol Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Cilostazol Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Injection Cilostazol
Table 4. Major Players ofFreeze-dried Powder Cilostazol
Table 5. Major Players of Oral Cilostazol
Table 6. Global Cilostazol Sales byType (2020-2025) & (K Pcs)
Table 7. Global Cilostazol Sales Market Share byType (2020-2025)
Table 8. Global Cilostazol Revenue byType (2020-2025) & ($ million)
Table 9. Global Cilostazol Revenue Market Share byType (2020-2025)
Table 10. Global Cilostazol Sale Price byType (2020-2025) & (USD/Pcs)
Table 11. Global Cilostazol Sale by Application (2020-2025) & (K Pcs)
Table 12. Global Cilostazol Sale Market Share by Application (2020-2025)
Table 13. Global Cilostazol Revenue by Application (2020-2025) & ($ million)
Table 14. Global Cilostazol Revenue Market Share by Application (2020-2025)
Table 15. Global Cilostazol Sale Price by Application (2020-2025) & (USD/Pcs)
Table 16. Global Cilostazol Sales by Company (2020-2025) & (K Pcs)
Table 17. Global Cilostazol Sales Market Share by Company (2020-2025)
Table 18. Global Cilostazol Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Cilostazol Revenue Market Share by Company (2020-2025)
Table 20. Global Cilostazol Sale Price by Company (2020-2025) & (USD/Pcs)
Table 21. Key Manufacturers Cilostazol Producing Area Distribution and Sales Area
Table 22. Players Cilostazol Products Offered
Table 23. Cilostazol Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Cilostazol Sales by Geographic Region (2020-2025) & (K Pcs)
Table 27. Global Cilostazol Sales Market Share Geographic Region (2020-2025)
Table 28. Global Cilostazol Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Cilostazol Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Cilostazol Sales by Country/Region (2020-2025) & (K Pcs)
Table 31. Global Cilostazol Sales Market Share by Country/Region (2020-2025)
Table 32. Global Cilostazol Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Cilostazol Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Cilostazol Sales by Country (2020-2025) & (K Pcs)
Table 35. Americas Cilostazol Sales Market Share by Country (2020-2025)
Table 36. Americas Cilostazol Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Cilostazol Sales byType (2020-2025) & (K Pcs)
Table 38. Americas Cilostazol Sales by Application (2020-2025) & (K Pcs)
Table 39. APAC Cilostazol Sales by Region (2020-2025) & (K Pcs)
Table 40. APAC Cilostazol Sales Market Share by Region (2020-2025)
Table 41. APAC Cilostazol Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Cilostazol Sales byType (2020-2025) & (K Pcs)
Table 43. APAC Cilostazol Sales by Application (2020-2025) & (K Pcs)
Table 44. Europe Cilostazol Sales by Country (2020-2025) & (K Pcs)
Table 45. Europe Cilostazol Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Cilostazol Sales byType (2020-2025) & (K Pcs)
Table 47. Europe Cilostazol Sales by Application (2020-2025) & (K Pcs)
Table 48. Middle East & Africa Cilostazol Sales by Country (2020-2025) & (K Pcs)
Table 49. Middle East & Africa Cilostazol Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Cilostazol Sales byType (2020-2025) & (K Pcs)
Table 51. Middle East & Africa Cilostazol Sales by Application (2020-2025) & (K Pcs)
Table 52. Key Market Drivers & Growth Opportunities of Cilostazol
Table 53. Key Market Challenges & Risks of Cilostazol
Table 54. Key IndustryTrends of Cilostazol
Table 55. Cilostazol Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Cilostazol Distributors List
Table 58. Cilostazol Customer List
Table 59. Global Cilostazol SalesForecast by Region (2026-2031) & (K Pcs)
Table 60. Global Cilostazol RevenueForecast by Region (2026-2031) & ($ millions)
Table 61. Americas Cilostazol SalesForecast by Country (2026-2031) & (K Pcs)
Table 62. Americas Cilostazol Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 63. APAC Cilostazol SalesForecast by Region (2026-2031) & (K Pcs)
Table 64. APAC Cilostazol Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 65. Europe Cilostazol SalesForecast by Country (2026-2031) & (K Pcs)
Table 66. Europe Cilostazol RevenueForecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Cilostazol SalesForecast by Country (2026-2031) & (K Pcs)
Table 68. Middle East & Africa Cilostazol RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Global Cilostazol SalesForecast byType (2026-2031) & (K Pcs)
Table 70. Global Cilostazol RevenueForecast byType (2026-2031) & ($ millions)
Table 71. Global Cilostazol SalesForecast by Application (2026-2031) & (K Pcs)
Table 72. Global Cilostazol RevenueForecast by Application (2026-2031) & ($ millions)
Table 73. Pfizer Basic Information, Cilostazol Manufacturing Base, Sales Area and Its Competitors
Table 74. Pfizer Cilostazol Product Portfolios and Specifications
Table 75. Pfizer Cilostazol Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 76. Pfizer Main Business
Table 77. Pfizer Latest Developments
Table 78.Teva Basic Information, Cilostazol Manufacturing Base, Sales Area and Its Competitors
Table 79.Teva Cilostazol Product Portfolios and Specifications
Table 80.Teva Cilostazol Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 81.Teva Main Business
Table 82.Teva Latest Developments
Table 83. Otsuka Pharmaceutical Basic Information, Cilostazol Manufacturing Base, Sales Area and Its Competitors
Table 84. Otsuka Pharmaceutical Cilostazol Product Portfolios and Specifications
Table 85. Otsuka Pharmaceutical Cilostazol Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 86. Otsuka Pharmaceutical Main Business
Table 87. Otsuka Pharmaceutical Latest Developments
Table 88. Novartis Basic Information, Cilostazol Manufacturing Base, Sales Area and Its Competitors
Table 89. Novartis Cilostazol Product Portfolios and Specifications
Table 90. Novartis Cilostazol Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 91. Novartis Main Business
Table 92. Novartis Latest Developments
Table 93. Mylan Basic Information, Cilostazol Manufacturing Base, Sales Area and Its Competitors
Table 94. Mylan Cilostazol Product Portfolios and Specifications
Table 95. Mylan Cilostazol Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 96. Mylan Main Business
Table 97. Mylan Latest Developments
Table 98. Squibb Basic Information, Cilostazol Manufacturing Base, Sales Area and Its Competitors
Table 99. Squibb Cilostazol Product Portfolios and Specifications
Table 100. Squibb Cilostazol Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 101. Squibb Main Business
Table 102. Squibb Latest Developments
Table 103. Sandoz Basic Information, Cilostazol Manufacturing Base, Sales Area and Its Competitors
Table 104. Sandoz Cilostazol Product Portfolios and Specifications
Table 105. Sandoz Cilostazol Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 106. Sandoz Main Business
Table 107. Sandoz Latest Developments
Table 108. Hikma Pharmaceuticals Basic Information, Cilostazol Manufacturing Base, Sales Area and Its Competitors
Table 109. Hikma Pharmaceuticals Cilostazol Product Portfolios and Specifications
Table 110. Hikma Pharmaceuticals Cilostazol Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 111. Hikma Pharmaceuticals Main Business
Table 112. Hikma Pharmaceuticals Latest Developments
Table 113. GSK Basic Information, Cilostazol Manufacturing Base, Sales Area and Its Competitors
Table 114. GSK Cilostazol Product Portfolios and Specifications
Table 115. GSK Cilostazol Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 116. GSK Main Business
Table 117. GSK Latest Developments
Table 118. Mayne Pharma Basic Information, Cilostazol Manufacturing Base, Sales Area and Its Competitors
Table 119. Mayne Pharma Cilostazol Product Portfolios and Specifications
Table 120. Mayne Pharma Cilostazol Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 121. Mayne Pharma Main Business
Table 122. Mayne Pharma Latest Developments
Table 123. Bedford Laboratories Basic Information, Cilostazol Manufacturing Base, Sales Area and Its Competitors
Table 124. Bedford Laboratories Cilostazol Product Portfolios and Specifications
Table 125. Bedford Laboratories Cilostazol Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 126. Bedford Laboratories Main Business
Table 127. Bedford Laboratories Latest Developments
Table 128. Abbott Basic Information, Cilostazol Manufacturing Base, Sales Area and Its Competitors
Table 129. Abbott Cilostazol Product Portfolios and Specifications
Table 130. Abbott Cilostazol Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 131. Abbott Main Business
Table 132. Abbott Latest Developments
Table 133.Takeda Basic Information, Cilostazol Manufacturing Base, Sales Area and Its Competitors
Table 134.Takeda Cilostazol Product Portfolios and Specifications
Table 135.Takeda Cilostazol Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 136.Takeda Main Business
Table 137.Takeda Latest Developments
Table 138. Zhejiang Weikang Pharmaceutical Basic Information, Cilostazol Manufacturing Base, Sales Area and Its Competitors
Table 139. Zhejiang Weikang Pharmaceutical Cilostazol Product Portfolios and Specifications
Table 140. Zhejiang Weikang Pharmaceutical Cilostazol Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 141. Zhejiang Weikang Pharmaceutical Main Business
Table 142. Zhejiang Weikang Pharmaceutical Latest Developments
Table 143. Chongqing Pharscin pharmaceutical Basic Information, Cilostazol Manufacturing Base, Sales Area and Its Competitors
Table 144. Chongqing Pharscin pharmaceutical Cilostazol Product Portfolios and Specifications
Table 145. Chongqing Pharscin pharmaceutical Cilostazol Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 146. Chongqing Pharscin pharmaceutical Main Business
Table 147. Chongqing Pharscin pharmaceutical Latest Developments
Table 148. Chengdu Leer Pharmaceutical Basic Information, Cilostazol Manufacturing Base, Sales Area and Its Competitors
Table 149. Chengdu Leer Pharmaceutical Cilostazol Product Portfolios and Specifications
Table 150. Chengdu Leer Pharmaceutical Cilostazol Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 151. Chengdu Leer Pharmaceutical Main Business
Table 152. Chengdu Leer Pharmaceutical Latest Developments
Table 153. Yantai Yisheng Pharmaceutical Basic Information, Cilostazol Manufacturing Base, Sales Area and Its Competitors
Table 154. Yantai Yisheng Pharmaceutical Cilostazol Product Portfolios and Specifications
Table 155. Yantai Yisheng Pharmaceutical Cilostazol Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 156. Yantai Yisheng Pharmaceutical Main Business
Table 157. Yantai Yisheng Pharmaceutical Latest Developments
Table 158. Cadila Pharmaceuticals Basic Information, Cilostazol Manufacturing Base, Sales Area and Its Competitors
Table 159. Cadila Pharmaceuticals Cilostazol Product Portfolios and Specifications
Table 160. Cadila Pharmaceuticals Cilostazol Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 161. Cadila Pharmaceuticals Main Business
Table 162. Cadila Pharmaceuticals Latest Developments
LIST OFFIGURES
Figure 1. Picture of Cilostazol
Figure 2. Cilostazol Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Cilostazol Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Cilostazol Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Cilostazol Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Cilostazol Sales Market Share by Country/Region (2024)
Figure 10. Cilostazol Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Injection Cilostazol
Figure 12. Product Picture ofFreeze-dried Powder Cilostazol
Figure 13. Product Picture of Oral Cilostazol
Figure 14. Global Cilostazol Sales Market Share byType in 2025
Figure 15. Global Cilostazol Revenue Market Share byType (2020-2025)
Figure 16. Cilostazol Consumed in Hospital
Figure 17. Global Cilostazol Market: Hospital (2020-2025) & (K Pcs)
Figure 18. Cilostazol Consumed in Clinic
Figure 19. Global Cilostazol Market: Clinic (2020-2025) & (K Pcs)
Figure 20. Cilostazol Consumed in Others
Figure 21. Global Cilostazol Market: Others (2020-2025) & (K Pcs)
Figure 22. Global Cilostazol Sale Market Share by Application (2024)
Figure 23. Global Cilostazol Revenue Market Share by Application in 2025
Figure 24. Cilostazol Sales by Company in 2025 (K Pcs)
Figure 25. Global Cilostazol Sales Market Share by Company in 2025
Figure 26. Cilostazol Revenue by Company in 2025 ($ millions)
Figure 27. Global Cilostazol Revenue Market Share by Company in 2025
Figure 28. Global Cilostazol Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global Cilostazol Revenue Market Share by Geographic Region in 2025
Figure 30. Americas Cilostazol Sales 2020-2025 (K Pcs)
Figure 31. Americas Cilostazol Revenue 2020-2025 ($ millions)
Figure 32. APAC Cilostazol Sales 2020-2025 (K Pcs)
Figure 33. APAC Cilostazol Revenue 2020-2025 ($ millions)
Figure 34. Europe Cilostazol Sales 2020-2025 (K Pcs)
Figure 35. Europe Cilostazol Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa Cilostazol Sales 2020-2025 (K Pcs)
Figure 37. Middle East & Africa Cilostazol Revenue 2020-2025 ($ millions)
Figure 38. Americas Cilostazol Sales Market Share by Country in 2025
Figure 39. Americas Cilostazol Revenue Market Share by Country (2020-2025)
Figure 40. Americas Cilostazol Sales Market Share byType (2020-2025)
Figure 41. Americas Cilostazol Sales Market Share by Application (2020-2025)
Figure 42. United States Cilostazol Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada Cilostazol Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico Cilostazol Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil Cilostazol Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC Cilostazol Sales Market Share by Region in 2025
Figure 47. APAC Cilostazol Revenue Market Share by Region (2020-2025)
Figure 48. APAC Cilostazol Sales Market Share byType (2020-2025)
Figure 49. APAC Cilostazol Sales Market Share by Application (2020-2025)
Figure 50. China Cilostazol Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan Cilostazol Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea Cilostazol Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia Cilostazol Revenue Growth 2020-2025 ($ millions)
Figure 54. India Cilostazol Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia Cilostazol Revenue Growth 2020-2025 ($ millions)
Figure 56. ChinaTaiwan Cilostazol Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe Cilostazol Sales Market Share by Country in 2025
Figure 58. Europe Cilostazol Revenue Market Share by Country (2020-2025)
Figure 59. Europe Cilostazol Sales Market Share byType (2020-2025)
Figure 60. Europe Cilostazol Sales Market Share by Application (2020-2025)
Figure 61. Germany Cilostazol Revenue Growth 2020-2025 ($ millions)
Figure 62.France Cilostazol Revenue Growth 2020-2025 ($ millions)
Figure 63. UK Cilostazol Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy Cilostazol Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia Cilostazol Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa Cilostazol Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa Cilostazol Sales Market Share byType (2020-2025)
Figure 68. Middle East & Africa Cilostazol Sales Market Share by Application (2020-2025)
Figure 69. Egypt Cilostazol Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa Cilostazol Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel Cilostazol Revenue Growth 2020-2025 ($ millions)
Figure 72.Turkey Cilostazol Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries Cilostazol Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Cilostazol in 2025
Figure 75. Manufacturing Process Analysis of Cilostazol
Figure 76. Industry Chain Structure of Cilostazol
Figure 77. Channels of Distribution
Figure 78. Global Cilostazol Sales MarketForecast by Region (2026-2031)
Figure 79. Global Cilostazol Revenue Market ShareForecast by Region (2026-2031)
Figure 80. Global Cilostazol Sales Market ShareForecast byType (2026-2031)
Figure 81. Global Cilostazol Revenue Market ShareForecast byType (2026-2031)
Figure 82. Global Cilostazol Sales Market ShareForecast by Application (2026-2031)
Figure 83. Global Cilostazol Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cilostazol Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Cilostazol by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Cilostazol by Country/Region, 2020, 2024 & 2031
2.2 Cilostazol Segment by Type
2.2.1 Injection Cilostazol
2.2.2 Freeze-dried Powder Cilostazol
2.2.3 Oral Cilostazol
2.3 Cilostazol Sales by Type
2.3.1 Global Cilostazol Sales Market Share by Type (2020-2025)
2.3.2 Global Cilostazol Revenue and Market Share by Type (2020-2025)
2.3.3 Global Cilostazol Sale Price by Type (2020-2025)
2.4 Cilostazol Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Cilostazol Sales by Application
2.5.1 Global Cilostazol Sale Market Share by Application (2020-2025)
2.5.2 Global Cilostazol Revenue and Market Share by Application (2020-2025)
2.5.3 Global Cilostazol Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Cilostazol Breakdown Data by Company
3.1.1 Global Cilostazol Annual Sales by Company (2020-2025)
3.1.2 Global Cilostazol Sales Market Share by Company (2020-2025)
3.2 Global Cilostazol Annual Revenue by Company (2020-2025)
3.2.1 Global Cilostazol Revenue by Company (2020-2025)
3.2.2 Global Cilostazol Revenue Market Share by Company (2020-2025)
3.3 Global Cilostazol Sale Price by Company
3.4 Key Manufacturers Cilostazol Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Cilostazol Product Location Distribution
3.4.2 Players Cilostazol Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR CILOSTAZOL BY GEOGRAPHIC REGION
4.1 World Historic Cilostazol Market Size by Geographic Region (2020-2025)
4.1.1 Global Cilostazol Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Cilostazol Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Cilostazol Market Size by Country/Region (2020-2025)
4.2.1 Global Cilostazol Annual Sales by Country/Region (2020-2025)
4.2.2 Global Cilostazol Annual Revenue by Country/Region (2020-2025)
4.3 Americas Cilostazol Sales Growth
4.4 APAC Cilostazol Sales Growth
4.5 Europe Cilostazol Sales Growth
4.6 Middle East & Africa Cilostazol Sales Growth
5 AMERICAS
5.1 Americas Cilostazol Sales by Country
5.1.1 Americas Cilostazol Sales by Country (2020-2025)
5.1.2 Americas Cilostazol Revenue by Country (2020-2025)
5.2 Americas Cilostazol Sales by Type (2020-2025)
5.3 Americas Cilostazol Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cilostazol Sales by Region
6.1.1 APAC Cilostazol Sales by Region (2020-2025)
6.1.2 APAC Cilostazol Revenue by Region (2020-2025)
6.2 APAC Cilostazol Sales by Type (2020-2025)
6.3 APAC Cilostazol Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Cilostazol by Country
7.1.1 Europe Cilostazol Sales by Country (2020-2025)
7.1.2 Europe Cilostazol Revenue by Country (2020-2025)
7.2 Europe Cilostazol Sales by Type (2020-2025)
7.3 Europe Cilostazol Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cilostazol by Country
8.1.1 Middle East & Africa Cilostazol Sales by Country (2020-2025)
8.1.2 Middle East & Africa Cilostazol Revenue by Country (2020-2025)
8.2 Middle East & Africa Cilostazol Sales by Type (2020-2025)
8.3 Middle East & Africa Cilostazol Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Cilostazol
10.3 Manufacturing Process Analysis of Cilostazol
10.4 Industry Chain Structure of Cilostazol
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Cilostazol Distributors
11.3 Cilostazol Customer
12 WORLD FORECAST REVIEW FOR CILOSTAZOL BY GEOGRAPHIC REGION
12.1 Global Cilostazol Market Size Forecast by Region
12.1.1 Global Cilostazol Forecast by Region (2026-2031)
12.1.2 Global Cilostazol Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Cilostazol Forecast by Type (2026-2031)
12.7 Global Cilostazol Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Cilostazol Product Portfolios and Specifications
13.1.3 Pfizer Cilostazol Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Teva
13.2.1 Teva Company Information
13.2.2 Teva Cilostazol Product Portfolios and Specifications
13.2.3 Teva Cilostazol Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Teva Main Business Overview
13.2.5 Teva Latest Developments
13.3 Otsuka Pharmaceutical
13.3.1 Otsuka Pharmaceutical Company Information
13.3.2 Otsuka Pharmaceutical Cilostazol Product Portfolios and Specifications
13.3.3 Otsuka Pharmaceutical Cilostazol Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Otsuka Pharmaceutical Main Business Overview
13.3.5 Otsuka Pharmaceutical Latest Developments
13.4 Novartis
13.4.1 Novartis Company Information
13.4.2 Novartis Cilostazol Product Portfolios and Specifications
13.4.3 Novartis Cilostazol Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Novartis Main Business Overview
13.4.5 Novartis Latest Developments
13.5 Mylan
13.5.1 Mylan Company Information
13.5.2 Mylan Cilostazol Product Portfolios and Specifications
13.5.3 Mylan Cilostazol Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Mylan Main Business Overview
13.5.5 Mylan Latest Developments
13.6 Squibb
13.6.1 Squibb Company Information
13.6.2 Squibb Cilostazol Product Portfolios and Specifications
13.6.3 Squibb Cilostazol Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Squibb Main Business Overview
13.6.5 Squibb Latest Developments
13.7 Sandoz
13.7.1 Sandoz Company Information
13.7.2 Sandoz Cilostazol Product Portfolios and Specifications
13.7.3 Sandoz Cilostazol Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Sandoz Main Business Overview
13.7.5 Sandoz Latest Developments
13.8 Hikma Pharmaceuticals
13.8.1 Hikma Pharmaceuticals Company Information
13.8.2 Hikma Pharmaceuticals Cilostazol Product Portfolios and Specifications
13.8.3 Hikma Pharmaceuticals Cilostazol Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Hikma Pharmaceuticals Main Business Overview
13.8.5 Hikma Pharmaceuticals Latest Developments
13.9 GSK
13.9.1 GSK Company Information
13.9.2 GSK Cilostazol Product Portfolios and Specifications
13.9.3 GSK Cilostazol Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 GSK Main Business Overview
13.9.5 GSK Latest Developments
13.10 Mayne Pharma
13.10.1 Mayne Pharma Company Information
13.10.2 Mayne Pharma Cilostazol Product Portfolios and Specifications
13.10.3 Mayne Pharma Cilostazol Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Mayne Pharma Main Business Overview
13.10.5 Mayne Pharma Latest Developments
13.11 Bedford Laboratories
13.11.1 Bedford Laboratories Company Information
13.11.2 Bedford Laboratories Cilostazol Product Portfolios and Specifications
13.11.3 Bedford Laboratories Cilostazol Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Bedford Laboratories Main Business Overview
13.11.5 Bedford Laboratories Latest Developments
13.12 Abbott
13.12.1 Abbott Company Information
13.12.2 Abbott Cilostazol Product Portfolios and Specifications
13.12.3 Abbott Cilostazol Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Abbott Main Business Overview
13.12.5 Abbott Latest Developments
13.13 Takeda
13.13.1 Takeda Company Information
13.13.2 Takeda Cilostazol Product Portfolios and Specifications
13.13.3 Takeda Cilostazol Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Takeda Main Business Overview
13.13.5 Takeda Latest Developments
13.14 Zhejiang Weikang Pharmaceutical
13.14.1 Zhejiang Weikang Pharmaceutical Company Information
13.14.2 Zhejiang Weikang Pharmaceutical Cilostazol Product Portfolios and Specifications
13.14.3 Zhejiang Weikang Pharmaceutical Cilostazol Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Zhejiang Weikang Pharmaceutical Main Business Overview
13.14.5 Zhejiang Weikang Pharmaceutical Latest Developments
13.15 Chongqing Pharscin pharmaceutical
13.15.1 Chongqing Pharscin pharmaceutical Company Information
13.15.2 Chongqing Pharscin pharmaceutical Cilostazol Product Portfolios and Specifications
13.15.3 Chongqing Pharscin pharmaceutical Cilostazol Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Chongqing Pharscin pharmaceutical Main Business Overview
13.15.5 Chongqing Pharscin pharmaceutical Latest Developments
13.16 Chengdu Leer Pharmaceutical
13.16.1 Chengdu Leer Pharmaceutical Company Information
13.16.2 Chengdu Leer Pharmaceutical Cilostazol Product Portfolios and Specifications
13.16.3 Chengdu Leer Pharmaceutical Cilostazol Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Chengdu Leer Pharmaceutical Main Business Overview
13.16.5 Chengdu Leer Pharmaceutical Latest Developments
13.17 Yantai Yisheng Pharmaceutical
13.17.1 Yantai Yisheng Pharmaceutical Company Information
13.17.2 Yantai Yisheng Pharmaceutical Cilostazol Product Portfolios and Specifications
13.17.3 Yantai Yisheng Pharmaceutical Cilostazol Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Yantai Yisheng Pharmaceutical Main Business Overview
13.17.5 Yantai Yisheng Pharmaceutical Latest Developments
13.18 Cadila Pharmaceuticals
13.18.1 Cadila Pharmaceuticals Company Information
13.18.2 Cadila Pharmaceuticals Cilostazol Product Portfolios and Specifications
13.18.3 Cadila Pharmaceuticals Cilostazol Sales, Revenue, Price and Gross Margin (2020-2025)
13.18.4 Cadila Pharmaceuticals Main Business Overview
13.18.5 Cadila Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Cilostazol Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Cilostazol Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Injection Cilostazol
Table 4. Major Players ofFreeze-dried Powder Cilostazol
Table 5. Major Players of Oral Cilostazol
Table 6. Global Cilostazol Sales byType (2020-2025) & (K Pcs)
Table 7. Global Cilostazol Sales Market Share byType (2020-2025)
Table 8. Global Cilostazol Revenue byType (2020-2025) & ($ million)
Table 9. Global Cilostazol Revenue Market Share byType (2020-2025)
Table 10. Global Cilostazol Sale Price byType (2020-2025) & (USD/Pcs)
Table 11. Global Cilostazol Sale by Application (2020-2025) & (K Pcs)
Table 12. Global Cilostazol Sale Market Share by Application (2020-2025)
Table 13. Global Cilostazol Revenue by Application (2020-2025) & ($ million)
Table 14. Global Cilostazol Revenue Market Share by Application (2020-2025)
Table 15. Global Cilostazol Sale Price by Application (2020-2025) & (USD/Pcs)
Table 16. Global Cilostazol Sales by Company (2020-2025) & (K Pcs)
Table 17. Global Cilostazol Sales Market Share by Company (2020-2025)
Table 18. Global Cilostazol Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Cilostazol Revenue Market Share by Company (2020-2025)
Table 20. Global Cilostazol Sale Price by Company (2020-2025) & (USD/Pcs)
Table 21. Key Manufacturers Cilostazol Producing Area Distribution and Sales Area
Table 22. Players Cilostazol Products Offered
Table 23. Cilostazol Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Cilostazol Sales by Geographic Region (2020-2025) & (K Pcs)
Table 27. Global Cilostazol Sales Market Share Geographic Region (2020-2025)
Table 28. Global Cilostazol Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Cilostazol Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Cilostazol Sales by Country/Region (2020-2025) & (K Pcs)
Table 31. Global Cilostazol Sales Market Share by Country/Region (2020-2025)
Table 32. Global Cilostazol Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Cilostazol Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Cilostazol Sales by Country (2020-2025) & (K Pcs)
Table 35. Americas Cilostazol Sales Market Share by Country (2020-2025)
Table 36. Americas Cilostazol Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Cilostazol Sales byType (2020-2025) & (K Pcs)
Table 38. Americas Cilostazol Sales by Application (2020-2025) & (K Pcs)
Table 39. APAC Cilostazol Sales by Region (2020-2025) & (K Pcs)
Table 40. APAC Cilostazol Sales Market Share by Region (2020-2025)
Table 41. APAC Cilostazol Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Cilostazol Sales byType (2020-2025) & (K Pcs)
Table 43. APAC Cilostazol Sales by Application (2020-2025) & (K Pcs)
Table 44. Europe Cilostazol Sales by Country (2020-2025) & (K Pcs)
Table 45. Europe Cilostazol Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Cilostazol Sales byType (2020-2025) & (K Pcs)
Table 47. Europe Cilostazol Sales by Application (2020-2025) & (K Pcs)
Table 48. Middle East & Africa Cilostazol Sales by Country (2020-2025) & (K Pcs)
Table 49. Middle East & Africa Cilostazol Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Cilostazol Sales byType (2020-2025) & (K Pcs)
Table 51. Middle East & Africa Cilostazol Sales by Application (2020-2025) & (K Pcs)
Table 52. Key Market Drivers & Growth Opportunities of Cilostazol
Table 53. Key Market Challenges & Risks of Cilostazol
Table 54. Key IndustryTrends of Cilostazol
Table 55. Cilostazol Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Cilostazol Distributors List
Table 58. Cilostazol Customer List
Table 59. Global Cilostazol SalesForecast by Region (2026-2031) & (K Pcs)
Table 60. Global Cilostazol RevenueForecast by Region (2026-2031) & ($ millions)
Table 61. Americas Cilostazol SalesForecast by Country (2026-2031) & (K Pcs)
Table 62. Americas Cilostazol Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 63. APAC Cilostazol SalesForecast by Region (2026-2031) & (K Pcs)
Table 64. APAC Cilostazol Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 65. Europe Cilostazol SalesForecast by Country (2026-2031) & (K Pcs)
Table 66. Europe Cilostazol RevenueForecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Cilostazol SalesForecast by Country (2026-2031) & (K Pcs)
Table 68. Middle East & Africa Cilostazol RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Global Cilostazol SalesForecast byType (2026-2031) & (K Pcs)
Table 70. Global Cilostazol RevenueForecast byType (2026-2031) & ($ millions)
Table 71. Global Cilostazol SalesForecast by Application (2026-2031) & (K Pcs)
Table 72. Global Cilostazol RevenueForecast by Application (2026-2031) & ($ millions)
Table 73. Pfizer Basic Information, Cilostazol Manufacturing Base, Sales Area and Its Competitors
Table 74. Pfizer Cilostazol Product Portfolios and Specifications
Table 75. Pfizer Cilostazol Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 76. Pfizer Main Business
Table 77. Pfizer Latest Developments
Table 78.Teva Basic Information, Cilostazol Manufacturing Base, Sales Area and Its Competitors
Table 79.Teva Cilostazol Product Portfolios and Specifications
Table 80.Teva Cilostazol Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 81.Teva Main Business
Table 82.Teva Latest Developments
Table 83. Otsuka Pharmaceutical Basic Information, Cilostazol Manufacturing Base, Sales Area and Its Competitors
Table 84. Otsuka Pharmaceutical Cilostazol Product Portfolios and Specifications
Table 85. Otsuka Pharmaceutical Cilostazol Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 86. Otsuka Pharmaceutical Main Business
Table 87. Otsuka Pharmaceutical Latest Developments
Table 88. Novartis Basic Information, Cilostazol Manufacturing Base, Sales Area and Its Competitors
Table 89. Novartis Cilostazol Product Portfolios and Specifications
Table 90. Novartis Cilostazol Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 91. Novartis Main Business
Table 92. Novartis Latest Developments
Table 93. Mylan Basic Information, Cilostazol Manufacturing Base, Sales Area and Its Competitors
Table 94. Mylan Cilostazol Product Portfolios and Specifications
Table 95. Mylan Cilostazol Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 96. Mylan Main Business
Table 97. Mylan Latest Developments
Table 98. Squibb Basic Information, Cilostazol Manufacturing Base, Sales Area and Its Competitors
Table 99. Squibb Cilostazol Product Portfolios and Specifications
Table 100. Squibb Cilostazol Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 101. Squibb Main Business
Table 102. Squibb Latest Developments
Table 103. Sandoz Basic Information, Cilostazol Manufacturing Base, Sales Area and Its Competitors
Table 104. Sandoz Cilostazol Product Portfolios and Specifications
Table 105. Sandoz Cilostazol Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 106. Sandoz Main Business
Table 107. Sandoz Latest Developments
Table 108. Hikma Pharmaceuticals Basic Information, Cilostazol Manufacturing Base, Sales Area and Its Competitors
Table 109. Hikma Pharmaceuticals Cilostazol Product Portfolios and Specifications
Table 110. Hikma Pharmaceuticals Cilostazol Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 111. Hikma Pharmaceuticals Main Business
Table 112. Hikma Pharmaceuticals Latest Developments
Table 113. GSK Basic Information, Cilostazol Manufacturing Base, Sales Area and Its Competitors
Table 114. GSK Cilostazol Product Portfolios and Specifications
Table 115. GSK Cilostazol Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 116. GSK Main Business
Table 117. GSK Latest Developments
Table 118. Mayne Pharma Basic Information, Cilostazol Manufacturing Base, Sales Area and Its Competitors
Table 119. Mayne Pharma Cilostazol Product Portfolios and Specifications
Table 120. Mayne Pharma Cilostazol Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 121. Mayne Pharma Main Business
Table 122. Mayne Pharma Latest Developments
Table 123. Bedford Laboratories Basic Information, Cilostazol Manufacturing Base, Sales Area and Its Competitors
Table 124. Bedford Laboratories Cilostazol Product Portfolios and Specifications
Table 125. Bedford Laboratories Cilostazol Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 126. Bedford Laboratories Main Business
Table 127. Bedford Laboratories Latest Developments
Table 128. Abbott Basic Information, Cilostazol Manufacturing Base, Sales Area and Its Competitors
Table 129. Abbott Cilostazol Product Portfolios and Specifications
Table 130. Abbott Cilostazol Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 131. Abbott Main Business
Table 132. Abbott Latest Developments
Table 133.Takeda Basic Information, Cilostazol Manufacturing Base, Sales Area and Its Competitors
Table 134.Takeda Cilostazol Product Portfolios and Specifications
Table 135.Takeda Cilostazol Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 136.Takeda Main Business
Table 137.Takeda Latest Developments
Table 138. Zhejiang Weikang Pharmaceutical Basic Information, Cilostazol Manufacturing Base, Sales Area and Its Competitors
Table 139. Zhejiang Weikang Pharmaceutical Cilostazol Product Portfolios and Specifications
Table 140. Zhejiang Weikang Pharmaceutical Cilostazol Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 141. Zhejiang Weikang Pharmaceutical Main Business
Table 142. Zhejiang Weikang Pharmaceutical Latest Developments
Table 143. Chongqing Pharscin pharmaceutical Basic Information, Cilostazol Manufacturing Base, Sales Area and Its Competitors
Table 144. Chongqing Pharscin pharmaceutical Cilostazol Product Portfolios and Specifications
Table 145. Chongqing Pharscin pharmaceutical Cilostazol Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 146. Chongqing Pharscin pharmaceutical Main Business
Table 147. Chongqing Pharscin pharmaceutical Latest Developments
Table 148. Chengdu Leer Pharmaceutical Basic Information, Cilostazol Manufacturing Base, Sales Area and Its Competitors
Table 149. Chengdu Leer Pharmaceutical Cilostazol Product Portfolios and Specifications
Table 150. Chengdu Leer Pharmaceutical Cilostazol Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 151. Chengdu Leer Pharmaceutical Main Business
Table 152. Chengdu Leer Pharmaceutical Latest Developments
Table 153. Yantai Yisheng Pharmaceutical Basic Information, Cilostazol Manufacturing Base, Sales Area and Its Competitors
Table 154. Yantai Yisheng Pharmaceutical Cilostazol Product Portfolios and Specifications
Table 155. Yantai Yisheng Pharmaceutical Cilostazol Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 156. Yantai Yisheng Pharmaceutical Main Business
Table 157. Yantai Yisheng Pharmaceutical Latest Developments
Table 158. Cadila Pharmaceuticals Basic Information, Cilostazol Manufacturing Base, Sales Area and Its Competitors
Table 159. Cadila Pharmaceuticals Cilostazol Product Portfolios and Specifications
Table 160. Cadila Pharmaceuticals Cilostazol Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 161. Cadila Pharmaceuticals Main Business
Table 162. Cadila Pharmaceuticals Latest Developments
LIST OFFIGURES
Figure 1. Picture of Cilostazol
Figure 2. Cilostazol Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Cilostazol Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Cilostazol Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Cilostazol Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Cilostazol Sales Market Share by Country/Region (2024)
Figure 10. Cilostazol Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Injection Cilostazol
Figure 12. Product Picture ofFreeze-dried Powder Cilostazol
Figure 13. Product Picture of Oral Cilostazol
Figure 14. Global Cilostazol Sales Market Share byType in 2025
Figure 15. Global Cilostazol Revenue Market Share byType (2020-2025)
Figure 16. Cilostazol Consumed in Hospital
Figure 17. Global Cilostazol Market: Hospital (2020-2025) & (K Pcs)
Figure 18. Cilostazol Consumed in Clinic
Figure 19. Global Cilostazol Market: Clinic (2020-2025) & (K Pcs)
Figure 20. Cilostazol Consumed in Others
Figure 21. Global Cilostazol Market: Others (2020-2025) & (K Pcs)
Figure 22. Global Cilostazol Sale Market Share by Application (2024)
Figure 23. Global Cilostazol Revenue Market Share by Application in 2025
Figure 24. Cilostazol Sales by Company in 2025 (K Pcs)
Figure 25. Global Cilostazol Sales Market Share by Company in 2025
Figure 26. Cilostazol Revenue by Company in 2025 ($ millions)
Figure 27. Global Cilostazol Revenue Market Share by Company in 2025
Figure 28. Global Cilostazol Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global Cilostazol Revenue Market Share by Geographic Region in 2025
Figure 30. Americas Cilostazol Sales 2020-2025 (K Pcs)
Figure 31. Americas Cilostazol Revenue 2020-2025 ($ millions)
Figure 32. APAC Cilostazol Sales 2020-2025 (K Pcs)
Figure 33. APAC Cilostazol Revenue 2020-2025 ($ millions)
Figure 34. Europe Cilostazol Sales 2020-2025 (K Pcs)
Figure 35. Europe Cilostazol Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa Cilostazol Sales 2020-2025 (K Pcs)
Figure 37. Middle East & Africa Cilostazol Revenue 2020-2025 ($ millions)
Figure 38. Americas Cilostazol Sales Market Share by Country in 2025
Figure 39. Americas Cilostazol Revenue Market Share by Country (2020-2025)
Figure 40. Americas Cilostazol Sales Market Share byType (2020-2025)
Figure 41. Americas Cilostazol Sales Market Share by Application (2020-2025)
Figure 42. United States Cilostazol Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada Cilostazol Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico Cilostazol Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil Cilostazol Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC Cilostazol Sales Market Share by Region in 2025
Figure 47. APAC Cilostazol Revenue Market Share by Region (2020-2025)
Figure 48. APAC Cilostazol Sales Market Share byType (2020-2025)
Figure 49. APAC Cilostazol Sales Market Share by Application (2020-2025)
Figure 50. China Cilostazol Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan Cilostazol Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea Cilostazol Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia Cilostazol Revenue Growth 2020-2025 ($ millions)
Figure 54. India Cilostazol Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia Cilostazol Revenue Growth 2020-2025 ($ millions)
Figure 56. ChinaTaiwan Cilostazol Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe Cilostazol Sales Market Share by Country in 2025
Figure 58. Europe Cilostazol Revenue Market Share by Country (2020-2025)
Figure 59. Europe Cilostazol Sales Market Share byType (2020-2025)
Figure 60. Europe Cilostazol Sales Market Share by Application (2020-2025)
Figure 61. Germany Cilostazol Revenue Growth 2020-2025 ($ millions)
Figure 62.France Cilostazol Revenue Growth 2020-2025 ($ millions)
Figure 63. UK Cilostazol Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy Cilostazol Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia Cilostazol Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa Cilostazol Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa Cilostazol Sales Market Share byType (2020-2025)
Figure 68. Middle East & Africa Cilostazol Sales Market Share by Application (2020-2025)
Figure 69. Egypt Cilostazol Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa Cilostazol Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel Cilostazol Revenue Growth 2020-2025 ($ millions)
Figure 72.Turkey Cilostazol Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries Cilostazol Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Cilostazol in 2025
Figure 75. Manufacturing Process Analysis of Cilostazol
Figure 76. Industry Chain Structure of Cilostazol
Figure 77. Channels of Distribution
Figure 78. Global Cilostazol Sales MarketForecast by Region (2026-2031)
Figure 79. Global Cilostazol Revenue Market ShareForecast by Region (2026-2031)
Figure 80. Global Cilostazol Sales Market ShareForecast byType (2026-2031)
Figure 81. Global Cilostazol Revenue Market ShareForecast byType (2026-2031)
Figure 82. Global Cilostazol Sales Market ShareForecast by Application (2026-2031)
Figure 83. Global Cilostazol Revenue Market ShareForecast by Application (2026-2031)
More Publications
Global Angiography Imaging Systems Market Growth 2026-2032
US$ 3,660.00
May 2026
111 pages
Global Thromboelastography Machine Market Growth 2023-2029
US$ 3,660.00
January 2023
120 pages
Global Gynecology Disposable Biopsy Punches Market Growth 2024-2030
US$ 3,660.00
March 2024
92 pages
Global Pyridoxine Hydrochloride Market Growth 2025-2031
US$ 3,660.00
January 2025
83 pages
Global Bone and Joint Health Supplements Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
August 2025
139 pages
